Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-protein-activated inwardly rectifying potassium channel 1 (GIRK1, encoded by KCNJ3) is a subunit of the GIRK family of potassium channels that allows potassium ions to flow into, but less efficiently out of, excitable cells such as neurons and cardiac myocytes[1][3][5]. These tetrameric channels typically consist of GIRK1 in combination with other GIRK subunits (e.g., GIRK2, GIRK4), and are activated by the direct interaction of G protein βγ subunits, which are released upon activation of various GPCRs[1][3][5]. GIRK1-containing channels are key effectors in slowing heart rate in response to parasympathetic stimulation and in mediating inhibition in the central nervous system[2][4]. Activation hyperpolarizes the cell membrane, reduces excitability, and serves as a fundamental mechanism for physiological inhibition and rhythm modulation[1][3]. Dysregulation of GIRK1-associated channels contributes to several diseases, including cardiac arrhythmias and certain neuropsychiatric disorders, and selective activators and inhibitors are under investigation as therapeutic agents[3][5].
Drugs and neurotransmitters activate GIRK1-containing channels via G protein βγ subunits following GPCR activation, causing cell hyperpolarization - Direct binding and activation (for experimental small molecules such as ML297)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-protein-activated inwardly rectifying potassium channel 1 (GIRK1 (also known as Kir3.1)).